745598 |
FRONTIERS IN IMMUNOLOGY |
Characterization of a Cohort of Patients With LIG4 Deficiency Reveals the Founder Effect of p.R278L, Unique to the Chinese Population |
2021-09-24 |
10.3389/fimmu.2021.695993 |
Luo Xianze, Liu Qing, Jiang Jinqiu, Tang Wenjing, Ding Yuan, Zhou Lina, Yu Jie, Tang Xuemei, An Yunfei, Zhao Xiaodong |
745597 |
FRONTIERS IN IMMUNOLOGY |
Corrigendum: CX3CR1 But Not CCR2 Expression Is Required for the Development of Autoimmune Peripheral Neuropathy in Mice |
2021-09-24 |
10.3389/fimmu.2021.765892 |
Oladiran Oladayo, Shi Xiang Qun, Fournier Sylvie, Zhang Ji |
745596 |
FRONTIERS IN IMMUNOLOGY |
N6-Methyladenosine and Rheumatoid Arthritis: A Comprehensive Review |
2021-09-24 |
10.3389/fimmu.2021.731842 |
Wu Sha, Li Xiao-Feng, Wu Yuan-Yuan, Yin Su-Qin, Huang Cheng, Li Jun |
745595 |
FRONTIERS IN IMMUNOLOGY |
Isolation of Skin Leukocytes Uncovers Phagocyte Inflammatory Responses During Induction and Resolution of Cutaneous Inflammation in Fish |
2021-09-24 |
10.3389/fimmu.2021.725063 |
Soliman Amro M., Yoon Taekwan, Wang Jiahui, Stafford James L., Barreda Daniel R. |
745594 |
FRONTIERS IN IMMUNOLOGY |
Venetoclax or Ruxolitinib in Pre-Transplant Conditioning Lowers the Engraftment Barrier by Different Mechanisms in Allogeneic Stem Cell Transplant Recipients |
2021-09-24 |
10.3389/fimmu.2021.749094 |
Davis Joanne E., Du Kelei, Ludford-Menting Mandy J., Prabahran Ashvind, Wong Eric, Huntington Nicholas D., Koldej Rachel M., Ritchie David S. |
745593 |
FRONTIERS IN IMMUNOLOGY |
Comutations in DDR Pathways Predict Atezolizumab Response in Non-Small Cell Lung Cancer Patients |
2021-09-24 |
10.3389/fimmu.2021.708558 |
Xiong Anning, Nie Wei, Zhou Yan, Li Changhui, Gu Kai, Zhang Ding, Chen Shiqing, Wen Fengcai, Zhong Hua, Han Baohui, Zhang Xueyan |
745592 |
FRONTIERS IN IMMUNOLOGY |
Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol |
2021-09-24 |
10.3389/fimmu.2021.753319 |
Sablerolles Roos S. G., Goorhuis Abraham, GeurtsvanKessel Corine H., de Vries Rory D., Huckriede Anke L. W., Koopmans Marion P. G., Lafeber Melvin, Postma Douwe F., van Baarle Debbie, Visser Leo G., Dalm Virgil A. S. H., Kootstra Neeltje A., Rietdijk Wim J. R., van der Kuy P. Hugo M. |
745591 |
FRONTIERS IN IMMUNOLOGY |
α-Hemolysin-Aided Oligomerization of the Spike Protein RBD Resulted in Improved Immunogenicity and Neutralization Against SARS-CoV-2 Variants |
2021-09-24 |
10.3389/fimmu.2021.757691 |
Zou Jintao, Jing Haiming, Zhang Xiaoli, Liu Yiheng, Zhao Zhuo, Duan Lianli, Yuan Yue, Chen Zhifu, Gou Qiang, Xiong Qingshan, Li Sisi, Yang Feng, Zeng Hao, Zou Quanming, Zhang Jinyong |
745590 |
FRONTIERS IN IMMUNOLOGY |
Low Soluble Programmed Cell Death Protein 1 Levels After Allogeneic Stem Cell Transplantation Predict Moderate or Severe Chronic GvHD and Inferior Overall Survival |
2021-09-24 |
10.3389/fimmu.2021.694843 |
Kordelas Lambros, Buttkereit Ulrike, Heinemann Falko M., Horn Peter A., Giebel Bernd, Beelen Dietrich W., Reinhardt H. Christian, Rebmann Vera |
745589 |
FRONTIERS IN IMMUNOLOGY |
Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis In Vivo and Baseline Signaling Profile Associates With Treatment Response |
2021-09-24 |
10.3389/fimmu.2021.738481 |
Palmroth Maaria, Kuuliala Krista, Peltomaa Ritva, Virtanen Anniina, Kuuliala Antti, Kurttila Antti, Kinnunen Anna, Leirisalo-Repo Marjatta, Silvennoinen Olli, Isomäki Pia |